Members |
targetComponentId |
Gerliers sjukdom |
Epidemic vertigo |
graviditetsdiabetes mellitus, klass B |
Gestational diabetes mellitus |
graviditetsdiabetes mellitus, klass B1 |
Gestational diabetes mellitus |
graviditetsdiabetes mellitus, klass C |
Gestational diabetes mellitus |
graviditetsdiabetes mellitus, klass D |
Gestational diabetes mellitus |
graviditetsdiabetes mellitus, klass F |
Gestational diabetes mellitus |
graviditetsdiabetes mellitus, klass H |
Gestational diabetes mellitus |
graviditetsdiabetes mellitus, klass R |
Gestational diabetes mellitus |
graviditetsdiabetes mellitus, klass T |
Gestational diabetes mellitus |
fynd som rör TNM-stadium hos tumör i gestationell trofoblast |
American Joint Committee on Cancer allowable value |
Gianotti-Crosti syndrome |
Gianotti-Crosti syndrome |
Giant |
Gigantism |
Giant condyloma acuminatum |
Verrucous carcinoma |
Gianturco-Roehm-filter |
Vena cava filter |
Giesbergeria sinuosum |
Giesbergeria sinuosa |
tandköttslambå |
Flap (substance) |
gingival lamina dura, struktur |
Structure of lamina dura of tooth socket |
flickvän till patienten |
Girlfriend |
glabellalambå |
Flap (substance) |
prostatisk intraepitelial neoplasi, grad 3 |
High grade glandular intraepithelial neoplasia |
fragment av glas |
Glass fragment (physical object) |
glaukom orsakat av ögoninflammation |
Glaucoma due to eye inflammation (disorder) |
glaukom orsakat av silikonolja |
Glaucoma caused by silicone oil |
glaukom till följd av kirurgisk åtgärd |
Open angle glaucoma due to ocular surgery (disorder) |
misstänkt glaukom |
Glaucoma suspect |
Gliding bacteria |
Non-photosynthetic, non-fruiting gliding bacteria |
glioblastom, kategori |
Glioblastoma |
glioblastom |
Glioblastoma |
glipizid 10 mg, tablett med modifierad frisättning |
Product containing only glipizide in oral dose form (medicinal product form) |
glipizid 10 mg, depåtablett |
Product containing only glipizide in oral dose form (medicinal product form) |
glipizid 2,5 mg, tablett med modifierad frisättning |
Product containing only glipizide in oral dose form (medicinal product form) |
glipizid 2,5 mg, depåtablett |
Product containing only glipizide in oral dose form (medicinal product form) |
glipizid 5 mg, tablett med modifierad frisättning |
Product containing only glipizide in oral dose form (medicinal product form) |
glipizid 5 mg, depåtablett |
Product containing only glipizide in oral dose form (medicinal product form) |
globus abdominalis |
Functional bloating (disorder) |
fynd som rör TNM-stadieindelning av tumör i glottis |
American Joint Committee on Cancer allowable value |
Glucagonoma |
Glucagonoma of uncertain behavior (morphologic abnormality) |
Gluconobacter oxydans subspecies industrius |
Gluconobacter oxydans (organism) |
Gluconobacter oxydans subspecies melanogenes |
Gluconobacter oxydans (organism) |
Gluconobacter oxydans subspecies oxydans |
Gluconobacter oxydans (organism) |
Gluconobacter oxydans subspecies sphaericus |
Gluconobacter oxydans (organism) |
Gluconobacter oxydans subspecies suboxydans |
Gluconobacter oxydans (organism) |
glukos 10 %, infusionsvätska, lösning, flaska |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
glukos 15 %, infusionsvätska, lösning, flaska |
Product containing precisely glucose 150 milligram/1 milliliter conventional release solution for injection (clinical drug) |
glukos 20 %, infusionsvätska, lösning, polyetylenflaska 500 ml |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
glukos 20 %, infusionsvätska, lösning, flaska |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
glukos 40 %, infusionsvätska, lösning, flaska |
Glucose 400 mg/mL solution for injection |
glukos 50 %, infusionsvätska, lösning, flaska |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
glukos 50 %, injektionsvätska, lösning, förfylld spruta |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
glukos 70 %, infusionsvätska, lösning, påse |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
glukoshalt i prov |
Glucose level - finding |
dentinbondingmaterial, Gluma |
Dentine bonding agent (substance) |
Gluphosphate causing toxic effect |
Glyphosate toxicity |
glycerin 10 %, ögondroppar |
Glycerol 10 mg/mL eye solution |
glycerin 10 %, ögondroppar utan konserveringsmedel |
Glycerol 10 mg/mL eye solution |
glycerin 20 %, ögondroppar |
Product containing only glycerol in ocular dose form (medicinal product form) |
glycerin 20 %, ögondroppar utan konserveringsmedel |
Product containing only glycerol in ocular dose form (medicinal product form) |
glycerin 30 %, ögondroppar |
Product containing only glycerol in ocular dose form (medicinal product form) |
glycerin 30 %, ögondroppar utan konserveringsmedel |
Product containing only glycerol in ocular dose form (medicinal product form) |
glycerin 50 %, ögondroppar |
Glycerol 500 mg/mL eye solution |
glycerin 50 %, ögondroppar utan konserveringsmedel |
Glycerol 500 mg/mL eye solution |
glycerin 50 %, lösning |
Glycerol only product |
glycerol, suppositorium för spädbarn 1 g |
Product containing precisely glycerol 1 gram/1 each conventional release rectal suppository (clinical drug) |
glycerol, suppositorium för barn 2 g |
Glycerol 2 g rectal suppository |
glycerol, suppositorium för vuxna 4 g |
Product containing precisely glycerol 4 gram/1 each conventional release rectal suppository (clinical drug) |
Glycerol kinase deficiency |
Deficiency of glycerol kinase |
glyceryltrinitrat 0,4 %, salva |
Product containing only glyceryl trinitrate (medicinal product) |
nitroglycerin 2 mg, buckaltablett med modifierad frisättning |
Glyceryl trinitrate 2 mg buccal tablet |
nitroglycerin 3 mg, buckaltablett med modifierad frisättning |
Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug) |
nitroglycerin 5 mg, buckaltablett med modifierad frisättning |
Glyceryl trinitrate 5 mg buccal tablet |
nitroglycerinsprejallergi |
Allergy to nitroglycerin |
Glycosidase |
Glycosidase |
Glycosyltransferase |
Glycosyltransferase |
getmjölk |
Goat's milk |
Gomphocarpus physocarpus |
Asclepias physocarpus (organism) |
Gomphrena physocarpus |
Asclepias physocarpus (organism) |
Gorissennes tecken |
Jorissenne sign |
Goura cristata cristata |
Goura cristata (organism) |
Gout with other manifestation, NEC |
Gout |
Gouty nephropathy NOS |
Chronic gouty nephropathy |
Gouty nephropathy unspecified |
Chronic gouty nephropathy |
grad av dysplasi i adenom vid proximal resektionskant |
Histologic grade of dysplasia at proximal surgical margin |
graderingsvärden |
Grades |
Graft to organ NOC |
Grafting procedure |
Graft to organ NOC NOS |
Grafting procedure |
Grafting of bone, autogenous or bone bank |
Bone graft |
transplantation av nasolabiala lambåer |
Reconstruction using nasolabial flap of skin (procedure) |
transplantation av fascialambå |
Reconstruction using pedicle fascial flap (procedure) |
transplantation av bakre tibialambå |
Reconstruction using posterior tibial artery fasciocutaneous flap |
Grafting of tarsal or metatarsal |
Grafting of phalanges of foot |
Grahamella |
Bartonella |
Grahamella peromysci |
Bartonella peromysci |
Grahamella species |
Bartonella |
Grahamella talpae |
Bartonella peromysci |
Grahamellosis |
Bartonellosis |
grampositiva förgrenade hyfer |
Gram-positive branched filamentous bacilli present (finding) |
far- eller morförälder till patienten |
Grandparent |
Granuloma of lacrimal passages |
Lacrimal sac granuloma |
granulom i operationssår |
Granuloma of surgical wound (finding) |
granulovakuolär degeneration av typ Simchowicz |
Granulovacuolar degeneration (morphologic abnormality) |
Graphosid spider |
Order Araneae (organism) |